Something that was a conspiracy theory was born in pharmaceutical laboratories. I’m talking about a vaccine for diabetes.
A phenomenal business for pharmaceutical concerns.
In Poland, about 3.5 million people have diabetes, tens of millions in the United States, and hundreds of millions worldwide.
The market is enormous.
It is not clear what criteria will decide whether or not you have to vaccinate yourself.
Will it be like with the flu, where entire workplaces are vaccinated for free?
Probably the movement will be wide and on a global scale.
Nobody is worried about the fact that the vaccines cause diabetes in children …
The vaccine is tested on … children
A research group from the University of Tampere, under the leadership of Heikki Hyöta, a professor of virology, was a pioneer in the development of a vaccine that can prevent type 1 diabetes.
The research group identified enteroviruses belonging to the B group Coxsackie viruses that are associated with diabetes. A prototype vaccine was developed to prevent these viruses.
“It is already known that the vaccine is effective and safe for mice. The next step is to study the vaccine on humans”- says professor Hyöty.
In the first phase of the clinical trial, the vaccine will be tested on a group of adults.
In the second phase, the vaccine will be tested on children … and the study’s aim is to investigate both the safety of the vaccine and its effectiveness against enteroviruses.
In the third phase, they will investigate whether the vaccine prevents the onset of type 1 diabetes.
The third stage is officially supposed to take about seven years.
I’m curious whether they will speed up this date …
“The aim is to develop a vaccine that could prevent a significant amount of type 1 diabetes cases. In addition, the vaccine protects against enterovirus-related infections such as cold, myocarditis, meningitis and ear infections. However, in light of the current studies, the vaccine can not be used to treat existing diabetes, “explains Hyöty.
You have to admit the claims are big … one vaccine which cures many diseases.
Researchers admit that there is a danger.
The relationship between viral infections and type 1 diabetes has been studied for over 25 years at the Faculty of Medicine and Life Sciences at the University of Tampere.
The results indicate that one group of viruses, enteroviruses, play a role in the development of type 1 diabetes. They can infect cells that produce insulin in the pancreas and damage them permanently.
Who sponsors the vaccine studies?
The project is financed by the American company Provention Bio. The other partners are the Juvenile Diabetes Research Foundation, which is the largest foundation funding the type 1 diabetes research in the world, and the Finnish company Vactech Oy, which develops the required vaccine technology.
Professor Heikki Hyöta (University of Tampere) and professor Mikael Knip (University of Helsinki) were co-founders at Vactech Oy and thus led academic research about the development of a preventive vaccine.
Several other companies have participated in the development of the vaccine for diabetes.
Karolinska Institutet in Stockholm, several universities and research institutes in Finland and abroad, as well as Vactech Oy.
The research was also funded by several different groups, such as Finnish Academy, TEKES, Sigrid Juselius Foundation, Reino Lahtikari Foundation, Diabetes Research Foundation.
Now Think About it!
Now, please, pay attention to the conflict of interest.
Professor Heikki Hyöta is both the head of this research and co-owner of Vactech Oy, which sponsors the research.
Nobody invests in something that will become a failure.
Therefore, the research on the vaccine may have a pre-established goal (success).
Foto: https:element envanto by duallogic